Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy (Pt. Prodia Stem Cell Indonesia)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameAllogeneic Umbilical Cord Mesenchymal Stem Cell Therapy (Pt. Prodia Stem Cell Indonesia)
Drug Alias NameUC-MSC(Pt. Prodia Stem Cell Indonesia)
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAlopeciaMyocardial InfarctionDiabetic Nephropathies +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPt. Prodia Stem Cell Indonesia
China Registration ClassN/A

Develop Information

Active CompaniesPt. Prodia Stem Cell Indonesia
Inactive CompaniesN/A
Active IndicationsAlopeciaMyocardial InfarctionDiabetic Nephropathies +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A